Real-world effectiveness of palbociclib plus fulvestrant in advanced breast cancer: Results from a population-based cohort study

BACKGROUND: Real-world (RW) data may provide valuable information on the effectiveness and safety of medicines, which is particularly relevant for clinicians, patients and third-party payers. Evidence on the effectiveness of palbociclib plus fulvestrant is scarce, which highlights the need of additi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoso Borges, Fábio, Alves da Costa, Filipa, Ramos, Adriana, Ramos, Catarina, Bernardo, Catarina, Brito, Cláudia, Mayer-da-Silva, Alexandra, Furtado, Cláudia, Ferreira, Arlindo R., Martins-Branco, Diogo, Miranda, Ana, Lourenço, António
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859011/
https://www.ncbi.nlm.nih.gov/pubmed/35182993
http://dx.doi.org/10.1016/j.breast.2022.02.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8859011/
https://www.ncbi.nlm.nih.gov/pubmed/35182993
http://dx.doi.org/10.1016/j.breast.2022.02.005

Ejemplares similares